BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy
- Georgina Perez-Garcia
- , Mesude Bicak
- , Jean Vianney Haure-Mirande
- , Gissel M. Perez
- , Alena Otero-Pagan
- , Miguel A. Gama Sosa
- , Rita De Gasperi
- , Mary Sano
- , Carrolee Barlow
- , Fred H. Gage
- , Benjamin Readhead
- , Michelle E. Ehrlich
- , Sam Gandy
- , Gregory A. Elder
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations